Industry Specific

The impact of CFDA’s latest directive on overseas medical device manufacturers

On September 30th, 2016, China’s Food and Drug Administration issued a “Notice of the Release of the Second Batch of Medical Devices Exempted from Clinical Trials by the General Administration” (2016, No. 133) and began implementation on the date of publication. There were 267 items of Class II medical equipment listed that are exempted from […]